SuperworthMedtronic EPS MDT
Diluted earnings per share by quarter and over the last twelve months, from 2008.
- Last 12 months, to Jul 31, 2026
- $4.07
- Latest quarter, Q1 FY27
- $1.14
- +41% on a year earlier
- Fiscal year 2026
- $3.74
- +3% on the year before
Medtronic's earnings per share was $4.07 over the twelve months to Jul 31, 2026, up 12% on a year earlier.
In its latest quarter, Q1 FY27, it was $1.14, up 41% on the same quarter a year before.
Over the five fiscal years to FY2026 it grew 7% a year on average.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2026 | $3.74 | +3% |
| FY2025 | $3.62 | +32% |
| FY2024 | $2.75 | −2% |
| FY2023 | $2.82 | −24% |
| FY2022 | $3.73 | +40% |
| FY2021 | $2.66 | −25% |
| FY2020 | $3.55 | +4% |
| FY2019 | $3.42 | +51% |
| FY2018 | $2.26 | −22% |
| FY2017 | $2.89 | +17% |
| FY2016 | $2.48 | −7% |
| FY2015 | $2.68 | −11% |
| FY2014 | $3.01 | −11% |
| FY2013 | $3.38 | −1% |
| FY2012 | $3.41 | +19% |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q1 FY27 | $1.14 | +41% | $4.07 | |
| Q4 FY26 | $0.97 | +18% | $3.74 | |
| Q3 FY26 | $0.89 | −12% | $3.59 | |
| Q2 FY26 | $1.07 | +8% | $3.71 | |
| Q1 FY26 | $0.81 | +1% | $3.63 | |
| Q4 FY25 | $0.82 | +67% | $3.62 | |
| Q3 FY25 | $1.01 | +2% | $3.29 | |
| Q2 FY25 | $0.99 | +46% | $3.27 | |
| Q1 FY25 | $0.80 | +36% | $2.96 | |
| Q4 FY24 | $0.49 | −44% | $2.75 | |
| Q3 FY24 | $0.99 | +8% | $3.14 | |
| Q2 FY24 | $0.68 | +113% | $3.07 |
Against its peers
Companies in Medical - Devices nearest Medtronic's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| MDTMedtronic | $4.07 | +12% a year |
| SYKStryker | $9.65 | +28% a year |
| ABTAbbott Laboratories | $2.68 | −66% a year |
| BSXBoston Scientific | $2.47 | +47% a year |
| EWEdwards Lifesciences | $1.74 | −75% a year |
| GEHCGE HealthCare Technologies | $4.36 | −11% a year |
| DXCMDexCom | $2.52 | +76% a year |
| ZBHZimmer Biomet | $4.11 | +0% a year |
| Peer median | $2.68 |
Where Medtronic ranks
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Medtronic
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.